MCANDREW STEPHEN J 4
4 · Oncobiologics, Inc. · Filed Dec 26, 2017
Insider Transaction Report
Form 4
MCANDREW STEPHEN J
SVP Bus. Strat. & Dev.
Transactions
- Sale
Common Stock
2017-12-22$1.13/sh+15,705$17,747→ 50,899 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
- [F2]Includes shares of common stock underlying RSUs reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on December 22, 2016. The vesting of RSUs was accelerated such that 100% of the shares underlying the RSU vested on December 21, 2017.